PHARMACOKINETICS OF CONVENTIONAL AND SLOW-RELEASE VERAPAMIL

被引:23
作者
FOLLATH, F [1 ]
HA, HR [1 ]
SCHUTZ, E [1 ]
BUHLER, F [1 ]
机构
[1] UNIV HOSP BASEL, DEPT MED, DIV CLIN PHARMACOL, CH-4031 BASEL, SWITZERLAND
关键词
D O I
10.1111/j.1365-2125.1986.tb02864.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S149 / S153
页数:5
相关论文
共 17 条
[1]   INTER-SUBJECT AND INTRA-SUBJECT VARIATION IN THE 1ST-PASS ELIMINATION OF HIGHLY CLEARED DRUGS DURING CHRONIC DOSING - STUDIES WITH DEUTERATED VERAPAMIL [J].
EICHELBAUM, M ;
SOMOGYI, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (01) :47-53
[2]   EFFECTS OF VERAPAMIL ON P-R-INTERVALS IN RELATION TO VERAPAMIL PLASMA-LEVELS FOLLOWING SINGLE IV AND ORAL-ADMINISTRATION AND DURING CHRONIC TREATMENT [J].
EICHELBAUM, M ;
BIRKEL, P ;
GRUBE, E ;
GUTGEMANN, U ;
SOMOGYI, A .
KLINISCHE WOCHENSCHRIFT, 1980, 58 (18) :919-925
[3]  
FOLLATH F, 1980, CLIN INVEST MED, V3, P49
[4]   VERAPAMIL KINETICS IN NORMAL SUBJECTS AND PATIENTS WITH CORONARY-ARTERY SPASM [J].
FREEDMAN, SB ;
RICHMOND, DR ;
ASHLEY, JJ ;
KELLY, DT .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) :644-652
[5]   VERAPAMIL DISPOSITION KINETICS IN CHRONIC ATRIAL-FIBRILLATION [J].
KATES, RE ;
KEEFE, DLD ;
SCHWARTZ, J ;
HARAPAT, S ;
KIRSTEN, EB ;
HARRISON, DC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (01) :44-51
[6]  
KRIKLER D, 1974, EUR J CARDIOL, V2, P3
[7]   ONCE A DAY VERAPAMIL IN ESSENTIAL-HYPERTENSION [J].
MULLER, FB ;
HA, HR ;
HOTZ, H ;
SCHMIDLIN, O ;
FOLLATH, F ;
BUHLER, FR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S143-S147
[9]   RELATIONSHIP OF ANTIARRHYTHMIC TO INOTROPIC ACTIVITY AND ANTIARRHYTHMIC QUALITIES OF OPTICAL ISOMERS OF VERAPAMIL [J].
RASCHACK, M .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1976, 294 (03) :285-291
[10]   COMPARISON OF INTRAVENOUS AND ORAL VERAPAMIL DOSING [J].
REITER, MJ ;
SHAND, DG ;
PRITCHETT, ELC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (06) :711-720